| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 12 1531-1540, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
C Carriere, S Plaza, J Caboche, C Dozier, M Bailly, P Martin and S Saule
Centre National de la Recherche Scientifique, EP 56, Institut Pasteur de Lille, France.
We reported previously the characterization of Pax-QNR/Pax-6 products expressed in the avian neuroretina. Five proteins (48, 46, 43, 33, and 32 kDa) were characterized, among which the 33 and 32 kDa proteins are devoid of the paired domain. In contrast to the 48-kDa (containing an alternative paired exon 4a) and 46-kDa proteins exclusively located in the nucleus, the 43- (in which the paired exon 5 is spliced out), 33-, and 32-kDa proteins were also found in the cytoplasmic compartment. We report the identification of two nuclear targeting sequences: the basic LKRKLQR region (amino acids 206-212) located in the NH2 terminus of the homeodomain used by the p43 and 33/32 kDa proteins; and the paired exon 5 sequence. A case of human aniridia, where arginine 208 of LKRKLQR is mutated into a tryptophan, has been reported recently. We introduced this mutation into the Pax-QNR p46, p43, and p33/32 proteins. No effect on the nuclear localization or in transactivation potential of the proteins could be observed. Among the several Pax-QNR isoforms characterized, only p46 exhibited DNA-binding and transactivating properties on the Pax-QNR promoter. Deletions of parts of the protein showed that the Pax-6 transactivation domain is located in the carboxyl terminus of the protein.
This article has been cited by other articles:
![]() |
J. Favor, C. J. Gloeckner, A. Neuhauser-Klaus, W. Pretsch, R. Sandulache, S. Saule, and I. Zaus Relationship of Pax6 Activity Levels to the Extent of Eye Development in the Mouse, Mus musculus Genetics, July 1, 2008; 179(3): 1345 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zaccarini, F. P. Cordelieres, P. Martin, and S. Saule PAX6 P46 Binds Chromosomes in the Pericentromeric Region and Induces a Mitosis Defect When Overexpressed Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5408 - 5419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yan, W.-B. Liu, J. Qin, J. Liu, H.-G. Chen, X. Huang, L. Chen, S. Sun, M. Deng, L. Gong, et al. Protein Phosphatase-1 Modulates the Function of Pax-6, a Transcription Factor Controlling Brain and Eye Development J. Biol. Chem., May 11, 2007; 282(19): 13954 - 13965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Bruun, E. I. S. Thomassen, K. Kristiansen, G. Tylden, T. Holm, I. Mikkola, G. Bjorkoy, and T. Johansen The third helix of the homeodomain of paired class homeodomain proteins acts as a recognition helix both for DNA and protein interactions Nucleic Acids Res., May 10, 2005; 33(8): 2661 - 2675. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leconte, L. Lecoin, P. Martin, and S. Saule Pax6 Interacts with cVax and Tbx5 to Establish the Dorsoventral Boundary of the Developing Eye J. Biol. Chem., November 5, 2004; 279(45): 47272 - 47277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ploski, M. K. Shamsher, and A. Radu Paired-Type Homeodomain Transcription Factors Are Imported into the Nucleus by Karyopherin 13 Mol. Cell. Biol., June 1, 2004; 24(11): 4824 - 4834. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Punzo, S. Kurata, and W. J. Gehring The eyeless homeodomain is dispensable for eye development in Drosophila Genes & Dev., July 1, 2001; 15(13): 1716 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bryan and M. Morasso The Dlx3 protein harbors basic residues required for nuclear localization, transcriptional activity and binding to Msx1 J. Cell Sci., January 11, 2000; 113(22): 4013 - 4023. [Abstract] [PDF] |
||||
![]() |
I. Mikkola, J.-A. Bruun, G. Bjorkoy, T. Holm, and T. Johansen Phosphorylation of the Transactivation Domain of Pax6 by Extracellular Signal-regulated Kinase and p38 Mitogen-activated Protein Kinase J. Biol. Chem., May 21, 1999; 274(21): 15115 - 15126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ritz-Laser, A. Estreicher, N. Klages, S. Saule, and J. Philippe Pax-6 and Cdx-2/3 Interact to Activate Glucagon Gene Expression on the G1 Control Element J. Biol. Chem., February 12, 1999; 274(7): 4124 - 4132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Tomarev, P. Callaerts, L. Kos, R. Zinovieva, G. Halder, W. Gehring, and J. Piatigorsky Squid Pax-6 and eye development PNAS, March 18, 1997; 94(6): 2421 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Kovac, A. Emelyanov, M. Singh, N. Ashouian, and B. K. Birshtein BSAP (Pax5)-Importin alpha 1 (Rch1) Interaction Identifies a Nuclear Localization Sequence J. Biol. Chem., May 26, 2000; 275(22): 16752 - 16757. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mikkola, J.-A. Bruun, T. Holm, and T. Johansen Superactivation of Pax6-mediated Transactivation from Paired Domain-binding Sites by DNA-independent Recruitment of Different Homeodomain Proteins J. Biol. Chem., February 2, 2001; 276(6): 4109 - 4118. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Planque, L. Leconte, F. M. Coquelle, P. Martin, and S. Saule Specific Pax-6/Microphthalmia Transcription Factor Interactions Involve Their DNA-binding Domains and Inhibit Transcriptional Properties of Both Proteins J. Biol. Chem., July 27, 2001; 276(31): 29330 - 29337. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Planque, L. Leconte, F. M. Coquelle, S. Benkhelifa, P. Martin, M.-P. Felder-Schmittbuhl, and S. Saule Interaction of Maf Transcription Factors with Pax-6 Results in Synergistic Activation of the Glucagon Promoter J. Biol. Chem., September 14, 2001; 276(38): 35751 - 35760. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |